Synergistic Cytotoxic Effects by Combination Treatment of Genistein and Daidzein in Human Colorectal Cancer Cell |
Son, Seong-Min
(Dept. of Biological Sciences, Andong National University)
Lim, Seung-Hyun (Dept. of Biological Sciences, Andong National University) Kim, Hyo-Rim (Dept. of Biological Sciences, Andong National University) Kim, Min-Jeong (Dept. of Biological Sciences, Andong National University) Kim, Tae-Wan (Dept. of Food Science and Biotechnology, Andong National University) Lee, Jong-Hwa (Dept. of Food Science and Biotechnology, Andong National University) Kim, Jong-Sik (Dept. of Biological Sciences, Andong National University) |
1 | Rayalam, S., M. A Della-Fera, J. Y. Yang, H. J. Park, S. Ambati, and C. A Baile. 2007. Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes. J. Nutr. 137, 2668-2673 |
2 | Reiter, E., A Azzi, and J. M. Zingg. 2007. Enhanced anti-proliferative effects of combinatorial treatment of delta-tocopherol and resveratrol in human HMC-1 cells. Biofactors 30, 67-77 DOI |
3 | Sarkar, F. H. and Y. Li. 2002. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev. 21, 265-280 DOI ScienceOn |
4 | Schlachterman, A, F. Valle, K. M. Wall, N. G. Azios, L. Castillo, L. Morell, A V. Washington, L. A Cubano, and S. F. Dharmawardhane. 2008. Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl. Oncol. 1, 19-27 DOI |
5 | Surh, Y. J. 2003. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3, 768-780 DOI ScienceOn |
6 | Thomasset, S. C., D. P. Berry, G. Garcea, T. Marczylo, W. P. Steward, and A J. Gescher. 2007. Dietary polyphenolic phytochemicals-promising cancer chemopreventive agents in humans? A review of their clinical properties. Int. J. Cancer 120, 451-458 DOI ScienceOn |
7 | Wilson, L. C., S. J. Baek, A Call, and T. E. Eling. 2003. Nonsteroidal anti-inflammatory drug-activated gene (NAG-I) is induced by genistein through the expression of p53 in colorectal cancer cells. Int. J. Cancer 105, 747-753 DOI ScienceOn |
8 | Ye, F., J. Wu, T. Dunn, J. Yi, X. Tong, and D. Zhang. 2004. Inhibition of cyclooxygenase-2 activity in head and neck cancer cells by genistein. Cancer Lett. 211, 39-46 DOI ScienceOn |
9 | Baek, S. J., J. S. Kim, S. M. Moore, S. H. Lee, J. Martinez, and T. E. Eling. 2005. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-I, an antitumorigenic protein. Mol. Pharmacol. 67, 356-364 DOI ScienceOn |
10 | Banerjee, S., Y. Li, Z. Wang, and F. H. Sarkar. 2008. Multi-targeted therapy of cancer by genistein. Cancer Lett. 269, 226-242 DOI ScienceOn |
11 | Constantinou, A I., B. E. White, D. Tonetti, Y. Yang, W. Liang, W. Li, and R. B. van Breemen. 2005. The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumours. Eur. J. Cancer 41, 647-654 DOI ScienceOn |
12 | Hsieh, T. C. and J. M. Wu. 2008. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells. Int. J. Oncol. 33, 851-859 |
13 | Kelloff, G. J., C. W. Boone, J. A Crowell, V. E. Steele, R. Lubet, and C. C. Sigman. 1994. Chemopreventive drug development: perspectives and progress. Cancer Epidemiol. Biomarkers Prevo 3, 85-98 |
14 | Lamartiniere, C. A, J. Wang, M. Smith-Johnson, and I. E. Eltoum. 2002. Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicol. Sci. 65, 228-238 DOI ScienceOn |
15 | Liu, R. H. 2004. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J. Nutr. 134(12 Suppl), 3479S-3485S |
16 | Livak, K. J. and T. D. Schmittgen. 2001. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the TMCT Method. Methods 25, 402-408 DOI ScienceOn |
17 | Baek, S. J., L. C. Wilson, and T. E. Eling. 2002. Resveratrol enhances the expression of non-steroidal anti-inflammatory drug-activated gene (NAG-I) by increasing the expression of p53. Carcinogenesis 23, 425-434 DOI ScienceOn |